We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DWNYF market cap is 135.04M. The company's latest EPS is CNY 0.2173 and P/E is 0.41.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 950.01M | 1.02B | 1.17B | 1.28B | 1.15B |
| Operating Income | 285.42M | 308.47M | 349.86M | 379.5M | 249.15M |
| Net Income | 255.43M | 268.13M | 358.18M | 358.06M | 326M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 2.79B | 2.9B | 3.34B | 3.67B | 3.62B |
| Total Liabilities | 760.08M | 720.14M | 941.7M | 1.02B | 763.43M |
| Total Equity | 2.03B | 2.18B | 2.4B | 2.65B | 2.86B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 275.84M | 302.9M | 393.14M | 434.27M | 338.4M |
| Investing | -598.86M | 26.45M | -284.2M | -175.01M | -387.57M |
| Financing | 66.09M | -327.7M | -129.75M | -92.7M | 2.07M |
| Market Cap | 135.04M |
| Price to Earnings Ratio | 0.41 |
| Price to Sales Ratio | 0.12 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.05 |
| Dividend Yield | - |
| Shares Outstanding | 1.5B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Dawnrays Pharmaceutical Holdings Ltd (PK) |
| Address |
cricket square grand cayman KY1-1111 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
